Ameritas Investment Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.03M Buy
8,774
+3,347
+62% +$826K 0.09% 169
2021
Q2
$2.16M Sell
5,427
-1,429
-21% -$287K 0.1% 165
2021
Q1
$1.28M Buy
6,856
+621
+10% +$121K 0.11% 188
2020
Q4
$1.05M Buy
6,235
+175
+3% +$26.1K 0.2% 122
2020
Q3
$995K Hold
6,060
0.31% 86
2020
Q2
$995K Sell
6,060
-1,367
-18% -$210K 0.29% 90
2020
Q1
$1.03M Buy
7,427
+3,033
+69% +$417K 0.17% 111
2019
Q4
$578K Sell
4,394
-198
-4% -$23K 0.12% 166
2019
Q3
$514K Buy
+4,592
New +$511K 0.1% 177
2019
Q2
Sell
-2,752
Closed -$357K 576
2019
Q1
$357K Buy
+2,752
New +$335K 0.07% 224

Other funds holding LLY

Ameritas Investment Company's LLY Position: Q3 2021 in Review

Ameritas Investment Company increased its Eli Lilly (LLY) stake by 62% in Q3 2021, buying an estimated $826K and bringing the position to 8,774 shares worth $2.03M. The position accounts for 0.09% of the portfolio, ranked #169.

Ameritas Investment Company first reported a position in LLY in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.16M in Q2 2021. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • Ameritas Investment Company held 8,774 shares of Eli Lilly worth $2.03M as of Q3 2021.
  • Ameritas Investment Company bought 3,347 Eli Lilly shares in Q3 2021, an estimated $826K.
  • Eli Lilly made up 0.09% of Ameritas Investment Company's portfolio in Q3 2021, its #169 holding.
  • Ameritas Investment Company first reported a position in Eli Lilly in Q1 2019 and has held it in 10 quarters since.
  • Ameritas Investment Company's Eli Lilly position peaked at $2.16M in Q2 2021.
  • 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.